SLC5A2 and diabetes mellitus: SGLT2 inhibitors represent a transformative advancement in the management of diabetes, with profound benefits for cardiovascular and renal health; as such, mechanistic insights from molecular imaging of the appropriate pathways and targets may be impactful in optimizing diabetes care.